Generic alternatives for brand name drugs in Canada 2018, by spending share

Branded drugs for which generic alternatives were made available in Canada in 2018, by proportion of total drug spending

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

April 2019



Survey time period


Supplementary notes

Spending: Total cost of eligible prescription drugs, including the plan member’s portion as well as the plan sponsor’s portion net of any Product Listing Agreement discounts.
Traditional drugs: Medications that are easy to self-administer and require less intensive clinical monitoring, such as those used to treat diabetes and high blood pressure.
* Specialty drugs: Medications used to treat chronic, complex conditions such as severe rheumatoid arthritis, multiple sclerosis and cancer. Includes injectable and non-injectable drugs and have one or more of the following qualities: frequent dosing adjustments and intensive clinical monitoring; intensive patient training and compliance assistance; limited distribution; and/or specialized handling or administration.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Canadian pharmaceutical industry"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.